Search the Newsreel

5 Space Stocks Ready to Rocket Higher After the SpaceX Hangover

In this episode of Being Exponential, Luke Lango dives into five of the biggest space stocks shaping the rapidly expanding space economy: Redwire (RDW), BlackSky (BKSY), Rocket Lab (RKLB), AST SpaceMobile (ASTS), and SpaceX (SPCX).

RKLB Q2 Deep Dive: Iridium Acquisition, Neutron Progress, and Margin Pressures Shape Outlook

RKLB Q2 Deep Dive: Iridium Acquisition, Neutron Progress, and Margin Pressures Shape Outlook Aerospace and defense company Rocket Lab (NASDAQ:RKLB) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 62% year on year to $234.1 million. On top of that, …

Zai Lab Director William Lis Executes Sale of 8,506 ADS Shares Under Rule 10b5-1 Plan

William Lis, a director at Zai Lab Ltd (NASDAQ:ZLAB), sold 8,506 American Depositary Shares (ADS) on August 12, 2026, for $25 per ADS. This transaction was conducted as per a pre-established Rule 10b5-1 trading plan adopted in September 2025. Following the sale, Lis directly …

The Bull Case For Establishment Labs (ESTA) Could Change Following Raised 2026 Revenue Guidance And Narrowing Losses

Establishment Labs Holdings (ESTA) reported strong Q2 2026 results with increased sales to US$67.54 million and a narrowed net loss of US$11.75 million, leading to raised full-year 2026 revenue guidance to US$269-US$271 million. This positive update suggests growing operational momentum for its Motiva implants. …

William Lis Sells 8,506 Shares of Zai Lab (NASDAQ:ZLAB) Stock

Director William Lis of Zai Lab (NASDAQ:ZLAB) sold 8,506 shares of the company's stock for $212,650 on August 12th, reducing his direct holdings by 16.86% to 41,931 shares. This follows a previous sale of 7,040 shares in June. Zai Lab reported a quarterly loss …

Insider Selling: Zai Lab (NASDAQ:ZLAB) CFO Sells $15,475.00 in Stock

Zai Lab's CFO, Yajing Chen, recently sold 619 shares of ZLAB stock for $15,475, reducing her stake by 1.73%. This follows another sale of 2,264 shares in June for approximately $39,529. Despite these insider sales and the company's unprofitability, analysts maintain a "Moderate Buy" …

Birgit Girshick Sells 6,500 Shares of Charles River Laboratories International (NYSE:CRL) Stock

Birgit Girshick, CEO of Charles River Laboratories International (NYSE:CRL), sold 6,500 shares of the company's stock for approximately $1.82 million. This transaction, executed under a Rule 10b5-1 trading plan, reduced her ownership by 15.29%. The company recently reported strong quarterly EPS and revenue that …

Charles River Laboratories International (NYSE:CRL) EVP Sells $1,038,657.24 in Stock

Charles River Laboratories International's EVP, Shannon Parisotto, sold 3,714 shares of company stock for approximately $1.04 million, reducing her holdings by 43.59%. This transaction was conducted under a pre-arranged Rule 10b5-1 plan. The company recently reported adjusted earnings of $3.02 per share, exceeding estimates, …

Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors

Charles River Laboratories International Inc. (CRL) stock fell 1.09% to $281.27 on Thursday, despite a positive trading session for the broader market. This underperformance snapped a seven-day winning streak for the company's shares. The S&P 500 Index rose 0.65%, and the Dow Jones Industrial …

Quantum X Labs (QXL) gains from quantum deal but warns on going concern

Charles River Labs (CRL) CEO exercises 6,500 options and sells shares under 10b5-1 plan

Charles River Laboratories (CRL) CEO Birgit Girshick exercised stock options for 6,500 shares on August 11, 2026, at an exercise price of $179.66 per share. Simultaneously, she sold these 6,500 common shares at $279.90 per share. These transactions were conducted under a pre-arranged Rule …

Charles River (CRL) executive Parisotto exercises options, sells 3,714 shares under 10b5-1 plan

Shannon M. Parisotto, CEVP, Discovery & Safety Assessment at Charles River Laboratories International, exercised stock options for 3,714 shares at $179.66 per share and simultaneously sold the same number of shares at $279.66 per share. These transactions, executed on August 11, 2026, were conducted …

Quantum X Labs Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Mobix Labs (MOBX) to buy Special Project Delivery in all-stock deal, raises revenue outlook

Is Rocket Lab Stock a Safer Option for Space Investors Than SpaceX?

Key Points Rocket Lab's revenue rose 62% last quarter. It's been growing at a faster rate than SpaceX when comparing just space-related revenue. Expectations will inevitably be higher for SpaceX than Rocket Lab due to its higher valuation.These 10 stocks could mint the next …

Rocket Lab Clears a Major Hurdle on the Iridium Acquisition

This article first appeared on GuruFocus. Rocket Lab (NASDAQ:RKLB) fell 2.80% premarket after the launch and space systems company said the Hart-Scott-Rodino waiting period on its proposed acquisition of Iridium Communications (IRDM) expired yesterday, clearing US antitrust review. Rocket Lab also set out how …

Invesco reports 2.98M-share stake in Charles River Laboratories (CRL)

Invesco Ltd., a Bermuda-based parent holding company, has reported a significant passive ownership position in Charles River Laboratories International, Inc. (CRL) common stock. The firm beneficially owns 2,984,785 shares, representing 6.2% of the outstanding common stock, held by its investment advisory clients. Invesco maintains …

Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month High - Here's Why

Silicon Labs Q2 FY 2026: IoT Recovery Builds Momentum for Series 3 Platform

Silicon Labs reported strong Q2 FY 2026 earnings, showing sequential improvements in revenue, gross margin, and profitability, indicating a recovery in the IoT semiconductor sector. The company's new 22nm Series 3 platform is central to its strategy of moving into more complex, compute-heavy, and …

GeoVax Labs (GOVX) holders report 1.59% stake tied to 118,715 warrants

Ayrton Capital LLC, Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B, and Waqas Khatri collectively reported beneficial ownership of 118,715 shares of GeoVax Labs (GOVX) common stock through warrants. This represents a 1.59% stake based on 7,369,243 shares outstanding as of July …

Is Planet Labs The Cheapest Stock In The Space Economy?

Key Points Planet Labs’ stock has plunged more than 50% from its all-time high. It's cheaper than its peers, but investors shouldn’t ignore the red flags.10 stocks we like better than Planet Labs PBC › Planet Labs(NYSE: PL), a developer of satellite constellations, went …

Earnings call transcript: MediPharm Labs posts first profit since 2019 in Q2 2026

7,574 Shares in Astera Labs, Inc. $ALAB Bought by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. has acquired 7,574 shares of Astera Labs, Inc. (NASDAQ:ALAB) for approximately $3.66 million, marking a new position for the institutional investor. This move comes amidst Astera Labs' strong quarterly performance, with revenue increasing by 104.5% year-over-year and EPS beating analyst …

Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Johnson Rice

Johnson Rice upgraded Core Laboratories (NYSE:CLB) from a "hold" to a "buy" rating, setting a $21.00 price target. This upgrade implies a significant upside, although the broader analyst consensus remains "Hold." The company recently reported better-than-expected EPS but missed revenue estimates, while its CEO …

Dr. Reddy’s Laboratories (RDY) CEO API & Services Deepak Sapra resigns effective November 12, 2026

Dr. Reddy’s Laboratories announced that Deepak Sapra, CEO of API & Services and a Senior Management Personnel, has resigned to pursue outside opportunities. His resignation is effective November 12, 2026, and he will remain with the company until then to ensure a smooth transition …

GeoVax Labs, Inc. (GOVX) holders cap ownership at 4.99% with warrants

Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC collectively reported a 4.99% beneficial ownership in GeoVax Labs, Inc. (GOVX) as of June 2026, totaling 273,657 shares derived from exercisable warrants. This stake is capped at 4.99% due to blocker provisions in additional …

Silicon Labs: Medical Revenue Surges 78% To Record As IoT Design Wins Accelerate

Silicon Labs reported a record 78% year-over-year increase in Medical revenue for Q2, driven by accelerating IoT design wins and stronger demand across its portfolio. Total Q2 revenue rose 18% to $228 million, with significant growth in Industrial & Commercial and Home & Life …

Q2 2026 Medipharm Labs Corp Earnings Call Transcript

Innovana Thinklabs Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Abbott Laboratories (NYSE:ABT) Raised to Outperform at Wolfe Research

Wolfe Research upgraded Abbott Laboratories (NYSE:ABT) to "outperform" from "peer perform," setting a $130 price target, which suggests a 17.2% upside. This upgrade comes after Abbott's recent quarterly results surpassed expectations, with EPS of $1.31 and revenue of $12.59 billion, an increase of 13% …

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

GOVX: GEO-MVA targets a $1.3B vaccine market gap with expedited approval and scalable U.S. supply

GeoVax Labs, Inc. (GOVX) aims to disrupt the global MVA vaccine market with its GEO-MVA program, addressing a $1.3 billion demand through a fast-tracked regulatory process and scalable U.S. manufacturing. Additionally, the company is advancing Gedeptin® as a novel therapy for solid tumors, supported …

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

Why Medipharm Labs Corp stock surged yesterday

Citigroup Upgrades Establishment Labs to Buy From Neutral, Price Target is $92

Citigroup has upgraded its rating for Establishment Labs Holdings Inc. to 'Buy' from 'Neutral', setting a new price target of $92. This upgrade follows the company's recent Q2 2026 earnings report, where it exceeded revenue estimates and raised its full-year 2026 earnings guidance. Establishment …

Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More

This article details Wall Street analyst upgrades, downgrades, and initiations for various companies on Thursday, August 13, 2026, following the release of inline CPI data. Key movements include Five Below being upgraded to Buy at Jefferies and StubHub being cut to Underperform at Bank …